Signaturefd, LLC Neogenomics Inc Transaction History

Signaturefd, LLC

$5.4 Billion
Q2 2025

A detailed history of Signaturefd, LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Signaturefd, LLC holds 34 shares of NEO stock, worth $219. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 134 74.63%

Holding current value

$219

Previous $1,000 100.0%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 16, 2025	SELL	$6.4 - $10.27 $640 - $1,027	-100 Reduced 74.63%	34 $0
Q3 2024 Oct 21, 2024	SELL	$13.4 - $17.73 $20,100 - $26,595	-1,500 Reduced 91.8%	134 $1,000
Q2 2023 Aug 01, 2023	SELL	$14.1 - $19.83 $564 - $793	-40 Reduced 2.39%	1,634 $26,000
Q1 2023 Apr 28, 2023	SELL	$9.09 - $19.45 $1,372 - $2,936	-151 Reduced 8.27%	1,674 $29,000
Q4 2022 Jan 27, 2023	SELL	$6.45 - $12.07 $457 - $856	-71 Reduced 3.74%	1,825 $16,000
Q3 2022 Nov 08, 2022	BUY	$7.86 - $12.91 $13,118 - $21,546	1,669 Added 735.24%	1,896 $16,000
Q2 2022 Aug 10, 2022	SELL	$7.06 - $13.97 $2,873 - $5,685	-407 Reduced 64.2%	227 $2,000
Q1 2022 May 02, 2022	BUY	$12.15 - $35.28 $5,795 - $16,828	477 Added 303.82%	634 $8,000
Q4 2021 Jan 25, 2022	SELL	$30.49 - $48.49 $396 - $630	-13 Reduced 7.65%	157 $5,000
Q3 2021 Oct 28, 2021	BUY	$41.66 - $52.52 $1,791 - $2,258	43 Added 33.86%	170 $8,000
Q2 2021 Jul 26, 2021	SELL	$36.62 - $51.69 $1,171 - $1,654	-32 Reduced 20.13%	127 $6,000
Q1 2021 Apr 30, 2021	BUY	$41.56 - $59.88 $1,329 - $1,916	32 Added 25.2%	159 $8,000
Q4 2020 Feb 11, 2021	BUY	$36.08 - $56.47 $4,077 - $6,381	113 Added 807.14%	127 $7,000
Q3 2020 Nov 03, 2020	BUY	$33.26 - $40.48 $465 - $566	14 New	14 $1,000

Others Institutions Holding NEO

# of Institutions

281

Shares Held

127M

Call Options Held

942K

Put Options Held

172K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $813M
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account